<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Patient management following extremity fasciotomy</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Patient management following extremity fasciotomy</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Patient management following extremity fasciotomy</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">J Gregory Modrall, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Joseph L Mills, Sr, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John F Eidt, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kathryn A Collins, MD, PhD, FACS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 30, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H443284462"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Extremity fasciotomy is the only recognized treatment for acute compartment syndrome and may be limb saving. Reperfusion following fasciotomy causes local and systemic effects that can be life-threatening and can complicate wound management.</p><p>The management of the patient following extremity fasciotomy, including management of reperfusion, wound care, and methods and timing of fasciotomy wound closure, will be reviewed here. Preoperative management and the indications, diagnosis, and techniques used to perform fasciotomy are discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/358.html" rel="external">"Acute compartment syndrome of the extremities"</a> and  <a class="medical medical_review" href="/d/html/15205.html" rel="external">"Lower extremity fasciotomy techniques"</a>.)</p><p class="headingAnchor" id="H443283570"><span class="h1">ISCHEMIA-REPERFUSION</span><span class="headingEndMark"> — </span>Local and systemic consequences of ischemia-reperfusion occur after fasciotomy. Increased blood flow in the muscle following restoration of normal tissue pressure usually causes muscle edema. The extent of extremity swelling depends upon the duration and severity of ischemia, the predominant muscle cell type within a muscle, the location and mass of ischemic muscle, and the status of the venous circulation. </p><p>Animal studies show that cellular damage starts approximately three hours after a complete ischemic insult and is nearly complete by six hours [<a href="#rid1">1</a>]. In humans, the level of tolerance to an ischemic insult varies, and not all ischemic insults are complete. Patients with underlying peripheral artery disease may exhibit less than expected swelling due to the protective effects of preexisting arterial collaterals that lessen the severity of ischemia [<a href="#rid2">2</a>]. There is also evidence from animal studies that ischemic preconditioning in skeletal muscle may mitigate the severity of muscle injury, remote organ injury, and mortality after major ischemic events [<a href="#rid3">3,4</a>]. </p><p>Swelling may be limited if there is incomplete reperfusion due to microvascular thrombosis. With prolonged ischemia, a "no reflow phenomenon" occurs that is characterized by capillary occlusion from endothelial swelling, plugging of capillaries with red and white blood cells, and increased interstitial pressure [<a href="#rid5">5,6</a>]. Reperfusion may occur at the macrovascular level, but there is no tissue perfusion. Clinically, this manifests as myonecrosis with minimal extremity swelling. </p><p>Successful reperfusion liberates the byproducts of muscle ischemia and cell necrosis (rhabdomyolysis) into the circulation, including potassium, phosphate, organic acids, myoglobin, creatine kinase, and thromboplastin. The systemic effects of these byproducts may include hyperkalemia, hyperphosphatemia, metabolic acidosis, and myoglobinuria, which can cause acute kidney injury, elevation of serum creatine kinase levels, and disseminated intravascular coagulation. (See <a class="local">'Management of reperfusion'</a> below.) </p><p>Muscles differ in their susceptibility to ischemic injury based upon the predominant muscle fiber type that is present [<a href="#rid7">7</a>]. Type I fibers rely primarily on oxidative metabolism of triglycerides, making these fibers vulnerable to ischemia. In comparison, type II fibers use anaerobic metabolism of glycogen, and, as a result, these fibers tolerate ischemia to a greater degree. Differences in muscle fiber distribution may explain, in part, the higher incidence of compartment syndrome in the anterior compartment of the leg, compared with the superficial posterior compartment (<a class="graphic graphic_figure graphicRef68629" href="/d/graphic/68629.html" rel="external">figure 1</a>). The tibialis anterior muscle is comprised primarily of type I fibers, whereas the gastrocnemius muscle has primarily type II fibers. </p><p>Although fasciotomy leading to reperfusion is generally limb saving, crush injuries involving large muscle groups (eg, buttock, thigh) may be prone to life-threatening complications from reperfusion [<a href="#rid8">8,9</a>]. The magnitude of the reperfusion insult may be so severe that sudden cardiac arrest can occur as a consequence of hyperkalemia with or without severe metabolic acidosis. (See  <a class="medical medical_review" href="/d/html/15205.html" rel="external">"Lower extremity fasciotomy techniques", section on 'Contraindications'</a> and <a class="local">'Management of reperfusion'</a> below.)</p><p>Interruption of venous outflow due to venous obstruction or surgical ligation after trauma may aggravate swelling. In the injured extremity, venous repair of major veins of the leg, such as the femoral or popliteal vein, is performed whenever feasible to prevent increased venous pressure that can lead to prolonged muscle swelling and compartment syndrome. When the venous injury cannot be repaired, prophylactic fasciotomy is frequently performed. (See  <a class="medical medical_review" href="/d/html/15235.html" rel="external">"Severe upper extremity injury in the adult patient"</a> and  <a class="medical medical_review" href="/d/html/15205.html" rel="external">"Lower extremity fasciotomy techniques", section on 'Prevention'</a>.)</p><p class="headingAnchor" id="H443284400"><span class="h1">MANAGEMENT OF REPERFUSION</span><span class="headingEndMark"> — </span>The initial management of reperfusion injury is focused on restoration of intravascular volume, followed by prevention and treatment of associated metabolic abnormalities. The most serious abnormalities include hyperkalemia, metabolic acidosis, and acute kidney injury due to myoglobinuria.</p><p class="bulletIndent1"><span class="glyph">●</span>Hyperkalemia – Hyperkalemia is treated to prevent life-threatening arrhythmias or cardiac arrest. Treatment is initiated based upon the presence of peaked T waves on the electrocardiogram (<a class="graphic graphic_waveform graphicRef80441" href="/d/graphic/80441.html" rel="external">waveform 1</a>). (See  <a class="medical medical_review" href="/d/html/2342.html" rel="external">"Clinical manifestations of hyperkalemia in adults", section on 'Cardiac manifestations'</a>.)</p><p></p><p class="bulletIndent1">Peaked T waves in this setting are an indication for <strong>urgent</strong> therapy of hyperkalemia, since ongoing release of potassium from ischemic or necrotic muscle cells can lead to progressive and life-threatening hyperkalemia. Treatment of hyperkalemia in this setting may include multiple modalities, with intravenous calcium having the most rapid onset. In the absence of electrocardiographic changes, hyperkalemia can initially be managed by ensuring adequate urinary output, but careful monitoring of the serum potassium is warranted. The manifestations and treatment of hyperkalemia are discussed in detail elsewhere. (See  <a class="medical medical_review" href="/d/html/2332.html" rel="external">"Treatment and prevention of hyperkalemia in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Metabolic acidosis<strong> </strong>– Metabolic acidosis, usually lactic acidosis during reperfusion, may exacerbate hyperkalemia and induce hypotension. The initial management of lactic acidosis is focused on volume resuscitation to restore tissue perfusion, with a goal of achieving a urine output of 1 mL/kg per hour. Severe acidosis with an arterial pH below 7.10 to 7.15 may be treated with intravenous <a class="drug drug_general" data-topicid="9928" href="/d/drug information/9928.html" rel="external">sodium bicarbonate</a>. Issues related to the treatment of lactic acidosis are discussed in detail elsewhere. (See  <a class="medical medical_review" href="/d/html/2294.html" rel="external">"Bicarbonate therapy in lactic acidosis"</a> and  <a class="medical medical_review" href="/d/html/2291.html" rel="external">"Approach to the adult with metabolic acidosis", section on 'Overview of therapy'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Rhabdomyolysis and myoglobinuria – Rhabdomyolysis presents with elevated serum muscle enzymes (including creatine kinase), red to brown urine due to myoglobinuria if there is persistent renal function, and electrolyte abnormalities. Peak serum creatine kinase levels depend upon the volume of muscle breakdown and the muscle mass of the patient. Creatinine kinase values should be measured twice daily until decreasing levels are observed. (See  <a class="medical medical_review" href="/d/html/5169.html" rel="external">"Rhabdomyolysis: Clinical manifestations and diagnosis"</a>.)</p><p></p><p class="bulletIndent1">Aggressive <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> hydration is the primary initial therapy of myoglobinuria, lowering the risk of induction of acute kidney injury. Other treatments may include bicarbonate or <a class="drug drug_general" data-topicid="9587" href="/d/drug information/9587.html" rel="external">mannitol</a>. The prevention and treatment of heme pigment-induced acute kidney injury is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/d/html/14036.html" rel="external">"Prevention and treatment of heme pigment-induced acute kidney injury (including rhabdomyolysis)"</a>.)</p><p></p><p class="headingAnchor" id="H443284358"><span class="h2">Role of anticoagulation</span><span class="headingEndMark"> — </span>A late consequence of muscle ischemia is capillary occlusion. Some authors have recommended high-dose systemic anticoagulation (typically using <a class="drug drug_general" data-topicid="8518" href="/d/drug information/8518.html" rel="external">unfractionated heparin</a>) as a means of limiting progressive small vessel occlusion. Because many inflammatory mediators are generated by the activation of clotting, anticoagulation may serve a dual purpose by limiting coagulation and the associated inflammation and swelling [<a href="#rid10">10</a>]. </p><p>However, the risk of anticoagulation after fasciotomy may outweigh the theoretical benefits for many patients, and there are no convincing data to support its routine use in this setting. Anticoagulation is warranted for acute ischemia and compartment syndrome due to thromboembolism. </p><p class="headingAnchor" id="H443283577"><span class="h1">WOUND MANAGEMENT</span><span class="headingEndMark"> — </span>Although fasciotomy is mandated by the diagnosis of an acute compartment syndrome, the wounds created from the fasciotomy procedure are associated with significant morbidity. The goals of wound management include identifying and debriding nonviable muscle and avoiding further muscle injury from wound desiccation. The optimal technique for managing fasciotomy wounds and timing of closure is unclear because of limited data. </p><p>We suggest leaving fasciotomy wounds open rather than closure or graft coverage of the skin in the immediate postoperative period to facilitate assessment of tissue viability. Premature wound closure before adequate resolution of swelling can lead to recurrent compartment syndrome. Nonviable tissue within the wound can also lead to other wound complications such as infection. (See <a class="local">'Wound complications'</a> below.)</p><p>In the first 24 to 48 hours after fasciotomy, we prefer sterile <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> gauze dressings that allow frequent wound assessment. Thereafter, we use a combination of active skin reapproximation and negative pressure wound therapy (NPWT) to aid with primary wound closure. Each approach has its benefits. In a meta-analysis of fasciotomy closure techniques, active skin reapproximation, using either skin approximation systems or gradual suture reapproximation, had the highest wound closure rates compared with NPWT (92 versus 78 percent) but at the expense of a higher complication rate (14.8 to 18.4 percent versus 2.49 percent) [<a href="#rid11">11</a>]. </p><p>NPWT can be used until muscle swelling has regressed but by itself may not promote primary wound closure. If primary closure cannot be achieved within two weeks, we proceed with skin grafting. Some have suggested the use of synthetic skin replacement in the interim (See <a class="local">'Active skin reapproximation'</a> below and <a class="local">'Negative pressure wound therapy'</a> below and <a class="local">'Synthetic skin replacement'</a> below and <a class="local">'Skin closure'</a> below.)</p><p class="headingAnchor" id="H1324002669"><span class="h2">Active skin reapproximation</span><span class="headingEndMark"> — </span>A variety of methods can be used to limit skin retraction and promote apposition of the dermal edges in conjunction with NPWT, or for patients who are not candidates for NPWT while awaiting skin closure or grafting. If silastic bands are used in conjunction with NPWT, the sponge for the NPWT system should be placed superficial to the silastic bands. </p><p>Among the simpler, less costly approaches are placement at the time of the fasciotomy of cutaneous sutures, or silastic vessel loops anchored to staples on the skin edges (<a class="graphic graphic_figure graphicRef71739" href="/d/graphic/71739.html" rel="external">figure 2</a>) [<a href="#rid12">12,13</a>]. Commercially available devices for this purpose are available (eg, Sure-Close suturing system, Marburger Skin Approximation System, Wisebands device, Canica device) [<a href="#rid14">14-18</a>]. A small trial compared NPWT with wound approximation using the shoelace technique [<a href="#rid19">19</a>]. The time to wound closure was significantly longer in the NPWT group (19.1 versus 15.1 days), with 6 of 42 patients requiring skin grafts compared with 0 of 40 in the shoelace group. NPWT was also more costly. In a later trial, patients were randomly assigned to wound closure under tension (ie, shoelace closure) or NPWT [<a href="#rid20">20</a>]. Among patients who were not able to be closed at the initial return to the operating room, more patients experienced wound closure with the shoelace technique compared with NPWT (100 percent [5 of 5] versus 11 percent [1 of 9]). The trial was stopped early by the Institutional Review Board because of the large difference in treatment outcome. </p><p class="headingAnchor" id="H398898525"><span class="h2">Negative pressure wound therapy</span><span class="headingEndMark"> — </span>NPWT, also called vacuum-assisted wound closure, refers to wound dressing systems that intermittently or continuously apply subatmospheric pressure to the surface of a wound. NPWT decreases tissue edema, enhances local blood flow, promotes granulation tissue, and decreases bacterial colonization. The general mechanism of action of NPWT and the placement and management of the NPWT device are discussed separately. (See  <a class="medical medical_review" href="/d/html/2881.html" rel="external">"Negative pressure wound therapy"</a>.)</p><p>Although there are no randomized trials comparing NPWT with standard gauze dressings for fasciotomy closure, retrospective studies show a decrease in the time to skin closure or grafting [<a href="#rid21">21,22</a>]. The larger of these studies compared 458 wounds treated with NPWT with 270 treated with standard gauze dressings. The skin closure rate was significantly higher for NPWT compared with gauze dressings (83 versus 56 percent), and the time to skin closure was significantly lower (5.2 versus 6.5 days) [<a href="#rid21">21</a>].</p><p class="headingAnchor" id="H1590965870"><span class="h2">Synthetic skin replacement</span><span class="headingEndMark"> — </span>Temporary synthetic skin replacement (SSR) has been proposed as an alternative to NPWT, especially in children. A single-center retrospective study found that children treated with a temporary, bilaminate SSR was associated with fewer procedures, fewer days to definitive wound closure, and a shorter length of stay compared with NPWT [<a href="#rid23">23</a>]. This approach has not been validated in other studies, however.</p><p class="headingAnchor" id="H81875569"><span class="h2">Hyperbaric oxygen</span><span class="headingEndMark"> — </span>Animal studies and case reports describe hyperbaric oxygen as adjunct treatment for the management of wounds following fasciotomy [<a href="#rid24">24-32</a>]. Further research is needed to determine the appropriate role of hyperbaric oxygen therapy. (See  <a class="medical medical_review" href="/d/html/326.html" rel="external">"Hyperbaric oxygen therapy"</a>.) </p><p class="headingAnchor" id="H443283584"><span class="h2">Skin closure</span><span class="headingEndMark"> — </span>Once the viability of the muscle is confirmed and muscle swelling has regressed, skin closure becomes the primary focus. Skin closure is usually achieved by bringing the edges together primarily, skin grafting, or, less commonly, a myocutaneous flap. In an occasional patient, the wounds may be left to heal by secondary intention. Appropriate timing of the closure is important to avoid recurrent compartment syndrome that can occur by closing the skin prematurely. </p><p>Delayed skin closure is appealing because it offers definitive closure soon after fasciotomy. However, delayed skin closure is often not feasible due to residual swelling. One study found that delayed skin closure less than five days postoperatively produced an undesirable increase in intracompartment pressures (&gt;30 mmHg) in 7 of 12 patients [<a href="#rid33">33</a>]. The authors suggest that measuring intracompartment pressures during delayed skin closure might avoid this complication. Skin closure between 8 and 14 days postoperatively may decrease the incidence of wound complications and decrease the length of stay compared with later closure [<a href="#rid34">34,35</a>].</p><p>More extensive fasciotomy wounds, particularly open wounds associated with massive post-fasciotomy muscle swelling, could require several weeks to achieve closure. These wounds are candidates for closure with a skin graft [<a href="#rid34">34-37</a>]. Myocutaneous flap coverage is a rare adjunct that may be needed if neurovascular structures or vascular grafts are exposed. (See  <a class="medical medical_review" href="/d/html/15121.html" rel="external">"Surgical reconstruction of the lower extremity"</a>.)</p><p class="headingAnchor" id="H443283619"><span class="h1">COMPLICATIONS</span><span class="headingEndMark"> — </span>The complications related to fasciotomy are multifactorial. Most complications are related to the underlying condition or injury that indicated the need for compartment decompression. The acute compartment syndrome may cause further injury, and the lack of timely diagnosis and treatment of acute compartment syndrome can be catastrophic. The fasciotomy can be an additional source of morbidity. </p><p>Technical complications related to fasciotomy technique are largely preventable. Persistent or recurrent compartment syndrome can occur if fascial incisions are not adequate to permit complete decompression of the compartment or if selective fasciotomy has been performed [<a href="#rid36">36</a>]. (See  <a class="medical medical_review" href="/d/html/15205.html" rel="external">"Lower extremity fasciotomy techniques", section on 'Technical complications'</a>.)</p><p class="headingAnchor" id="H11098771"><span class="h2">Persistent neurologic deficits</span><span class="headingEndMark"> — </span>Persistent neurologic deficits are the most common complication of the treatment of extremity compartment syndrome [<a href="#rid38">38</a>]. Following lower extremity fasciotomy, impaired neurologic function of some type is evident in 7 to 36 percent of limbs [<a href="#rid39">39-41</a>]. Nerve injury is due to soft tissue trauma, nerve ischemia during the interval of increased compartment pressure, or as a consequence of the fasciotomy incisions or dissection. Nerve injury as a technical complication during fasciotomy is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/d/html/15205.html" rel="external">"Lower extremity fasciotomy techniques", section on 'Neurovascular injury'</a>.)</p><p>The most common neuropathic symptom is altered sensation at the margins of the incision, which was documented in 77 percent of patients in a retrospective review of 60 patients [<a href="#rid42">42</a>]. Chronic pain syndromes developed in 10 of these patients (17 percent) at a mean follow-up of 59 months. (See  <a class="medical medical_review" href="/d/html/5628.html" rel="external">"Complex regional pain syndrome in adults: Pathogenesis, clinical manifestations, and diagnosis"</a>.)</p><p>Pain management is a critical issue in many patients with persistent neurologic deficits. Appropriate referral to a pain specialist should be made if pain persists after all visible wounds have healed. (See  <a class="medical medical_review" href="/d/html/5630.html" rel="external">"Complex regional pain syndrome in adults: Treatment, prognosis, and prevention"</a> and  <a class="medical medical_review" href="/d/html/116196.html" rel="external">"Evaluation of chronic non-cancer pain in adults"</a> and  <a class="medical medical_review" href="/d/html/126111.html" rel="external">"Approach to the management of chronic non-cancer pain in adults"</a>.)</p><p class="headingAnchor" id="H443283633"><span class="h2">Wound complications</span><span class="headingEndMark"> — </span>Wound complications after fasciotomy may occur immediately in the postoperative period or be delayed for months to years. Early wound complications occur in up to 40 percent of patients following lower extremity fasciotomy [<a href="#rid34">34,39,43</a>]. Risk factors for wound complications include the presence of vascular injury, greater than an eight-hour time interval between the injury and fasciotomy, a lower extremity site, and prophylactic fasciotomy [<a href="#rid43">43</a>]. Issues related to prophylactic fasciotomy are discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/15205.html" rel="external">"Lower extremity fasciotomy techniques", section on 'Prevention'</a>.)</p><p>Wound infection occurs in 4 to 7 percent of extremity fasciotomies [<a href="#rid34">34,39</a>]. Prophylactic antibiotics should be given at the time of the fasciotomy procedure and discontinued within 24 hours. Wound infection is treated as indicated by positive wound cultures with antibiotics based upon sensitivity testing. (See  <a class="medical medical_review" href="/d/html/15205.html" rel="external">"Lower extremity fasciotomy techniques", section on 'Preparation'</a>.)</p><p>During fasciotomy, muscle devascularization may result from soft tissue debridement or during the fasciotomy procedure. In one study, repeat debridement for muscle necrosis or invasive sepsis was required in 16 percent of patients [<a href="#rid34">34</a>]. </p><p>Many authors have hypothesized that early closure with a skin graft decreases the risk of complications, but data to support this notion are limited. In one series, a significantly lower rate of wound complications was found for wounds closed with a split-thickness skin graft compared with skin closure (5 versus 51 percent) [<a href="#rid34">34</a>]. </p><p>Late wound complications are reported in 4 to 38 percent of limbs [<a href="#rid34">34,39,42,43</a>]. In a retrospective study of 60 patients, 26 percent had tethered scars, 13 percent had recurrent ulceration, 13 percent had muscle herniation, and 7 percent had tethered tendons [<a href="#rid42">42</a>]. Poor wound healing and late wound ulceration are more likely to occur in the presence of extremity ischemia.</p><p class="headingAnchor" id="H331922656"><span class="h2">Venous insufficiency</span><span class="headingEndMark"> — </span>Lower extremity fasciotomy may predispose the patient to the late development of chronic venous disease. The diagnosis and management of lower extremity chronic venous disease is discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/8181.html" rel="external">"Overview of lower extremity chronic venous disease"</a>.)</p><p>In one study of 17 patients with a history of lower extremity fasciotomy for trauma, 8 had signs or symptoms of venous insufficiency [<a href="#rid44">44</a>]. Comparisons were made between the injured and uninjured extremities in these patients. Indicators of calf muscle pump dysfunction, including significantly decreased mean ejection fraction (32 versus 61 percent) and significantly increased mean residual volume fraction (59 versus 22 percent), were found in the injured limbs.</p><p class="headingAnchor" id="H331922541"><span class="h2">Limb loss</span><span class="headingEndMark"> — </span>Acute lower extremity compartment syndrome is associated with a significant risk for limb loss [<a href="#rid38">38</a>]. Five to 21 percent of limbs treated with fasciotomy of the lower leg will require major amputation [<a href="#rid34">34,39,40,43,45</a>]. In multiple trauma patients, combined orthopedic and vascular injury, other severe injuries, or systemic factors may contribute to the need for amputation. The highest amputation rates occur in patients with vascular repairs that have occluded [<a href="#rid34">34</a>]. </p><p>Regardless of the mechanism causing the compartment syndrome, limb loss is generally related to persistent ischemia such as incomplete fasciotomy or severe arterial disease, underlying systemic disease, or other injuries and not usually from a fasciotomy procedure-related issue [<a href="#rid39">39</a>]. (See  <a class="medical medical_review" href="/d/html/15205.html" rel="external">"Lower extremity fasciotomy techniques", section on 'Technical complications'</a>.)</p><p>Amputation after upper extremity compartment syndrome is rare. Two of the larger series reported no upper extremity amputations in a total of 233 patients [<a href="#rid43">43,46</a>].</p><p class="headingAnchor" id="H443286216"><span class="h1">MORTALITY</span><span class="headingEndMark"> — </span>Reported mortality rates for patients requiring emergent lower extremity fasciotomy range from 11 to 25 percent [<a href="#rid36">36,39,40,45</a>]. Mortality is most often due to massive trauma, cardiopulmonary failure, or multisystem organ failure and usually not directly attributable to the fasciotomy procedure. In a series of 36 patients undergoing lower extremity fasciotomy for a variety of indications, multivariate analysis identified age &gt;50 years as a significant predictor of poor outcome (death, amputation, or extremity dysfunction) following fasciotomy [<a href="#rid40">40</a>]. Older patients were more likely to have undergone fasciotomy as a result of a vascular procedure. Trauma patients were younger and had better overall outcomes [<a href="#rid40">40,47</a>].</p><p>The mortality rate following upper extremity fasciotomy appears to be lower at approximately 3 percent [<a href="#rid46">46</a>]. In a retrospective review of 139 patients with traumatic brachial artery injury, there was no difference in mortality rate for patients who required fasciotomy compared with those who did not (3.4 versus 2.7 percent) [<a href="#rid46">46</a>]. </p><p class="headingAnchor" id="H188185867"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/118156.html" rel="external">"Society guideline links: Extremity compartment syndrome"</a>.)</p><p class="headingAnchor" id="H443284217"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Muscle reperfusion following extremity fasciotomy can lead to potentially life-threatening systemic complications and profound tissue swelling that complicates wound management. (See <a class="local">'Ischemia-reperfusion'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The initial management of the systemic complications of reperfusion injury is focused on restoration of intravascular volume, followed by prevention and treatment of associated metabolic abnormalities including hyperkalemia, metabolic acidosis and myoglobinuria, which may lead to acute kidney injury. (See <a class="local">'Management of reperfusion'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>We suggest <strong>not</strong> closing the skin wounds until the fifth day following fasciotomy to permit assessment of the severity of swelling and viability of the muscle (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). Premature closure before adequate resolution of swelling can lead to recurrent compartment syndrome. Nonviable tissue within the wound can also lead to other wound complications such as infection. (See <a class="local">'Skin closure'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>We use <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> gauze dressings in the immediate postoperative period to allow frequent wound evaluation and interval debridement of necrotic tissue, as needed. Once the fasciotomy wounds are stable, we use active tension (eg, shoelace technique) with negative pressure wound therapy (NPWT) to facilitate fasciotomy closure. (See <a class="local">'Wound management'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For wounds that cannot be closed within two weeks, we proceed with skin grafting, or sometimes myocutaneous flap coverage, but this is rarely necessary. In an occasional patient, the wounds may be left to heal by secondary intention. (See <a class="local">'Skin closure'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Persistent neurologic deficits following fasciotomy for acute compartment syndrome are common. Nerve injury can be due to soft tissue injury from the inciting traumatic event; nerve ischemia during the interval of decreased compartment perfusion; or as a consequence of the fasciotomy incisions, dissection, or muscle debridement. (See <a class="local">'Persistent neurologic deficits'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Wound complications are common, occurring in up to 40 percent of patients following lower extremity fasciotomy. Risk factors for wound complications include the presence of vascular injury, a greater than eight-hour time interval between the injury and fasciotomy, a lower extremity site, prophylactic fasciotomy, and premature fasciotomy wound closure. (See <a class="local">'Wound complications'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Lindsay TF, Liauw S, Romaschin AD, Walker PM. The effect of ischemia/reperfusion on adenine nucleotide metabolism and xanthine oxidase production in skeletal muscle. J Vasc Surg 1990; 12:8.</a></li><li><a class="nounderline abstract_t">Adiseshiah M, Round JM, Jones DA. Reperfusion injury in skeletal muscle: a prospective study in patients with acute limb ischaemia and claudicants treated by revascularization. Br J Surg 1992; 79:1026.</a></li><li><a class="nounderline abstract_t">Eberlin KR, McCormack MC, Nguyen JT, et al. Ischemic preconditioning of skeletal muscle mitigates remote injury and mortality. J Surg Res 2008; 148:24.</a></li><li><a class="nounderline abstract_t">Vaillancourt C, Shrier I, Vandal A, et al. Acute compartment syndrome: how long before muscle necrosis occurs? CJEM 2004; 6:147.</a></li><li><a class="nounderline abstract_t">Brooks, B. Pathologic changes in muscle as the result of disturbances of circulation. Arch Surg 1922; 5:188.</a></li><li><a class="nounderline abstract_t">Menger MD, Rücker M, Vollmar B. Capillary dysfunction in striated muscle ischemia/reperfusion: on the mechanisms of capillary "no-reflow". Shock 1997; 8:2.</a></li><li class="breakAll">Steinau, H-U. Major Limb Replantation and Postischemia Syndrome: Investigation of Acute Ischemia-Induced Myopathy and Reperfusion Injury, Springer Verlag, New York 1988.</li><li><a class="nounderline abstract_t">Malinoski DJ, Slater MS, Mullins RJ. Crush injury and rhabdomyolysis. Crit Care Clin 2004; 20:171.</a></li><li><a class="nounderline abstract_t">Odeh M. The role of reperfusion-induced injury in the pathogenesis of the crush syndrome. N Engl J Med 1991; 324:1417.</a></li><li><a class="nounderline abstract_t">Blaisdell FW. The pathophysiology of skeletal muscle ischemia and the reperfusion syndrome: a review. Cardiovasc Surg 2002; 10:620.</a></li><li><a class="nounderline abstract_t">Jauregui JJ, Yarmis SJ, Tsai J, et al. Fasciotomy closure techniques. J Orthop Surg (Hong Kong) 2017; 25:2309499016684724.</a></li><li><a class="nounderline abstract_t">Zorrilla P, Marín A, Gómez LA, Salido JA. Shoelace technique for gradual closure of fasciotomy wounds. J Trauma 2005; 59:1515.</a></li><li><a class="nounderline abstract_t">Berman SS, Schilling JD, McIntyre KE, et al. Shoelace technique for delayed primary closure of fasciotomies. Am J Surg 1994; 167:435.</a></li><li><a class="nounderline abstract_t">Matt SE, Johnson LS, Shupp JW, et al. Management of fasciotomy wounds--does the dressing matter? Am Surg 2011; 77:1656.</a></li><li><a class="nounderline abstract_t">Narayanan K, Futrell JW, Bentz M, Hurwitz D. Comparative clinical study of the sure-closure device with conventional wound closure techniques. Ann Plast Surg 1995; 35:485.</a></li><li><a class="nounderline abstract_t">Janzing HM, Broos PL. Dermatotraction: an effective technique for the closure of fasciotomy wounds: a preliminary report of fifteen patients. J Orthop Trauma 2001; 15:438.</a></li><li><a class="nounderline abstract_t">Barnea Y, Gur E, Amir A, et al. Our experience with Wisebands: a new skin and soft-tissue stretch device. Plast Reconstr Surg 2004; 113:862.</a></li><li><a class="nounderline abstract_t">Singh N, Bluman E, Starnes B, Andersen C. Dynamic wound closure for decompressive leg fasciotomy wounds. Am Surg 2008; 74:217.</a></li><li><a class="nounderline abstract_t">Kakagia D, Karadimas EJ, Drosos G, et al. Wound closure of leg fasciotomy: comparison of vacuum-assisted closure versus shoelace technique. A randomised study. Injury 2014; 45:890.</a></li><li><a class="nounderline abstract_t">Johnson LS, Chaar M, Ball CG, et al. Management of extremity fasciotomy sites prospective randomized evaluation of two techniques. Am J Surg 2018; 216:736.</a></li><li><a class="nounderline abstract_t">Zannis J, Angobaldo J, Marks M, et al. Comparison of fasciotomy wound closures using traditional dressing changes and the vacuum-assisted closure device. Ann Plast Surg 2009; 62:407.</a></li><li><a class="nounderline abstract_t">Yang CC, Chang DS, Webb LX. Vacuum-assisted closure for fasciotomy wounds following compartment syndrome of the leg. J Surg Orthop Adv 2006; 15:19.</a></li><li><a class="nounderline abstract_t">Bussell HR, Aufdenblatten CA, Gruenenfelder C, et al. Comparison of lower extremity fasciotomy wound closure techniques in children: vacuum-assisted closure device versus temporary synthetic skin replacement. Eur J Trauma Emerg Surg 2019; 45:809.</a></li><li><a class="nounderline abstract_t">Wattel F, Mathieu D, Nevière R, Bocquillon N. Acute peripheral ischaemia and compartment syndromes: a role for hyperbaric oxygenation. Anaesthesia 1998; 53 Suppl 2:63.</a></li><li><a class="nounderline abstract_t">Strauss MB, Hargens AR, Gershuni DH, et al. Delayed use of hyperbaric oxygen for treatment of a model anterior compartment syndrome. J Orthop Res 1986; 4:108.</a></li><li><a class="nounderline abstract_t">Tibbles PM, Edelsberg JS. Hyperbaric-oxygen therapy. N Engl J Med 1996; 334:1642.</a></li><li><a class="nounderline abstract_t">Weiland DE. Fasciotomy closure using simultaneous vacuum-assisted closure and hyperbaric oxygen. Am Surg 2007; 73:261.</a></li><li><a class="nounderline abstract_t">Abdullah MS, Al-Waili NS, Butler G, Baban NK. Hyperbaric oxygen as an adjunctive therapy for bilateral compartment syndrome, rhabdomyolysis and acute renal failure after heroin intake. Arch Med Res 2006; 37:559.</a></li><li><a class="nounderline abstract_t">Nylander G, Lewis D, Nordström H, Larsson J. Reduction of postischemic edema with hyperbaric oxygen. Plast Reconstr Surg 1985; 76:596.</a></li><li><a class="nounderline abstract_t">Uhl E, Sirsjö A, Haapaniemi T, et al. Hyperbaric oxygen improves wound healing in normal and ischemic skin tissue. Plast Reconstr Surg 1994; 93:835.</a></li><li><a class="nounderline abstract_t">Kolski JM, Mazolewski PJ, Stephenson LL, et al. Effect of hyperbaric oxygen therapy on testicular ischemia-reperfusion injury. J Urol 1998; 160:601.</a></li><li><a class="nounderline abstract_t">Greensmith JE. Hyperbaric oxygen therapy in extremity trauma. J Am Acad Orthop Surg 2004; 12:376.</a></li><li><a class="nounderline abstract_t">Wiger P, Tkaczuk P, Styf J. Secondary wound closure following fasciotomy for acute compartment syndrome increases intramuscular pressure. J Orthop Trauma 1998; 12:117.</a></li><li><a class="nounderline abstract_t">Johnson SB, Weaver FA, Yellin AE, et al. Clinical results of decompressive dermotomy-fasciotomy. Am J Surg 1992; 164:286.</a></li><li><a class="nounderline abstract_t">Papalambros EL, Panayiotopoulos YP, Bastounis E, et al. Prophylactic fasciotomy of the legs following acute arterial occlusion procedures. Int Angiol 1989; 8:120.</a></li><li><a class="nounderline abstract_t">Jensen SL, Sandermann J. Compartment syndrome and fasciotomy in vascular surgery. A review of 57 cases. Eur J Vasc Endovasc Surg 1997; 13:48.</a></li><li><a class="nounderline abstract_t">Sheridan GW, Matsen FA 3rd. Fasciotomy in the treatment of the acute compartment syndrome. J Bone Joint Surg Am 1976; 58:112.</a></li><li><a class="nounderline abstract_t">Ojike NI, Roberts CS, Giannoudis PV. Compartment syndrome of the thigh: a systematic review. Injury 2010; 41:133.</a></li><li><a class="nounderline abstract_t">Rush DS, Frame SB, Bell RM, et al. Does open fasciotomy contribute to morbidity and mortality after acute lower extremity ischemia and revascularization? J Vasc Surg 1989; 10:343.</a></li><li><a class="nounderline abstract_t">Heemskerk J, Kitslaar P. Acute compartment syndrome of the lower leg: retrospective study on prevalence, technique, and outcome of fasciotomies. World J Surg 2003; 27:744.</a></li><li><a class="nounderline abstract_t">Lagerstrom CF, Reed RL 2nd, Rowlands BJ, Fischer RP. Early fasciotomy for acute clinically evident posttraumatic compartment syndrome. Am J Surg 1989; 158:36.</a></li><li><a class="nounderline abstract_t">Fitzgerald AM, Gaston P, Wilson Y, et al. Long-term sequelae of fasciotomy wounds. Br J Plast Surg 2000; 53:690.</a></li><li><a class="nounderline abstract_t">Velmahos GC, Theodorou D, Demetriades D, et al. Complications and nonclosure rates of fasciotomy for trauma and related risk factors. World J Surg 1997; 21:247.</a></li><li><a class="nounderline abstract_t">Bermudez K, Knudson MM, Morabito D, Kessel O. Fasciotomy, chronic venous insufficiency, and the calf muscle pump. Arch Surg 1998; 133:1356.</a></li><li><a class="nounderline abstract_t">Ritenour AE, Dorlac WC, Fang R, et al. Complications after fasciotomy revision and delayed compartment release in combat patients. J Trauma 2008; 64:S153.</a></li><li><a class="nounderline abstract_t">Kim JY, Buck DW 2nd, Forte AJ, et al. Risk factors for compartment syndrome in traumatic brachial artery injuries: an institutional experience in 139 patients. J Trauma 2009; 67:1339.</a></li><li><a class="nounderline abstract_t">Kosir R, Moore FA, Selby JH, et al. Acute lower extremity compartment syndrome (ALECS) screening protocol in critically ill trauma patients. J Trauma 2007; 63:268.</a></li></ol></div><div id="topicVersionRevision">Topic 15660 Version 19.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2374259" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : The effect of ischemia/reperfusion on adenine nucleotide metabolism and xanthine oxidase production in skeletal muscle.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1422711" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Reperfusion injury in skeletal muscle: a prospective study in patients with acute limb ischaemia and claudicants treated by revascularization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18570927" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Ischemic preconditioning of skeletal muscle mitigates remote injury and mortality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17433166" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Acute compartment syndrome: how long before muscle necrosis occurs?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Pathologic changes in muscle as the result of disturbances of circulation</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9249906" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Capillary dysfunction in striated muscle ischemia/reperfusion: on the mechanisms of capillary "no-reflow".</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9249906" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Capillary dysfunction in striated muscle ischemia/reperfusion: on the mechanisms of capillary "no-reflow".</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14979336" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Crush injury and rhabdomyolysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2020298" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : The role of reperfusion-induced injury in the pathogenesis of the crush syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12453699" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : The pathophysiology of skeletal muscle ischemia and the reperfusion syndrome: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28176601" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Fasciotomy closure techniques.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16394934" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Shoelace technique for gradual closure of fasciotomy wounds.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8179090" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Shoelace technique for delayed primary closure of fasciotomies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22273225" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Management of fasciotomy wounds--does the dressing matter?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8579266" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Comparative clinical study of the sure-closure device with conventional wound closure techniques.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11514772" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Dermatotraction: an effective technique for the closure of fasciotomy wounds: a preliminary report of fifteen patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15108877" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Our experience with Wisebands: a new skin and soft-tissue stretch device.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18376685" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Dynamic wound closure for decompressive leg fasciotomy wounds.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22377275" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Wound closure of leg fasciotomy: comparison of vacuum-assisted closure versus shoelace technique. A randomised study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30064725" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Management of extremity fasciotomy sites prospective randomized evaluation of two techniques.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19325346" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Comparison of fasciotomy wound closures using traditional dressing changes and the vacuum-assisted closure device.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16603108" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Vacuum-assisted closure for fasciotomy wounds following compartment syndrome of the leg.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30014272" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Comparison of lower extremity fasciotomy wound closure techniques in children: vacuum-assisted closure device versus temporary synthetic skin replacement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9659073" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Acute peripheral ischaemia and compartment syndromes: a role for hyperbaric oxygenation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3950802" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Delayed use of hyperbaric oxygen for treatment of a model anterior compartment syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8628361" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Hyperbaric-oxygen therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17375783" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Fasciotomy closure using simultaneous vacuum-assisted closure and hyperbaric oxygen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16624660" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Hyperbaric oxygen as an adjunctive therapy for bilateral compartment syndrome, rhabdomyolysis and acute renal failure after heroin intake.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4034778" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Reduction of postischemic edema with hyperbaric oxygen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8134443" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Hyperbaric oxygen improves wound healing in normal and ischemic skin tissue.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9679936" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Effect of hyperbaric oxygen therapy on testicular ischemia-reperfusion injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15615503" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Hyperbaric oxygen therapy in extremity trauma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9503301" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Secondary wound closure following fasciotomy for acute compartment syndrome increases intramuscular pressure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1415931" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Clinical results of decompressive dermotomy-fasciotomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2592793" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Prophylactic fasciotomy of the legs following acute arterial occlusion procedures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9046914" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Compartment syndrome and fasciotomy in vascular surgery. A review of 57 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1249096" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Fasciotomy in the treatment of the acute compartment syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19555950" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Compartment syndrome of the thigh: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2778898" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Does open fasciotomy contribute to morbidity and mortality after acute lower extremity ischemia and revascularization?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12732999" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Acute compartment syndrome of the lower leg: retrospective study on prevalence, technique, and outcome of fasciotomies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2742047" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Early fasciotomy for acute clinically evident posttraumatic compartment syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11090326" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Long-term sequelae of fasciotomy wounds.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9015166" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Complications and nonclosure rates of fasciotomy for trauma and related risk factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9865656" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Fasciotomy, chronic venous insufficiency, and the calf muscle pump.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18376159" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Complications after fasciotomy revision and delayed compartment release in combat patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20009687" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Risk factors for compartment syndrome in traumatic brachial artery injuries: an institutional experience in 139 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17693823" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Acute lower extremity compartment syndrome (ALECS) screening protocol in critically ill trauma patients.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
